News

Omega-3 discovery moves us closer to 'precision nutrition'

Josh Barney
By Josh Barney
Oct. 22, 2023

University of Virginia School of Medicine researchers have obtained new insights into how African-American and Hispanic-American people’s genes influence their ability to use Omega-3 and Omega-6 fatty acids for good health. The findings are an important step toward “precision nutrition” — where a diet tailored to exactly what our bodies need can help us live longer, healthier lives.

Omega-3 and Omega-6 are “healthy fats.” We can get them from foods, but many people also take them as supplements. Omega-3 helps keep the immune system healthy and may lower the risk of heart disease, while Omega-6 promotes immune health and offers other benefits. These fatty acids also play important roles in the proper functioning of our cells. People with higher levels of the fatty acids circulating in their bloodstreams are thought to be at reduced risk of heart disease, type 2 diabetes, Alzheimer’s disease, breast cancer and other serious illnesses. 

Omega-3 and Omega-6 fatty acids are found in foods such as nuts and avocados.

There has been substantial research into how genes influence the body’s ability to use Omega-3 and Omega-6 among people of European descent, but there has been much less study among Americans of Hispanic and African descent. UVA’s Ani W. Manichaikul, PhD, and colleagues set out to address that disparity. Their new findings reveal broad similarities among the groups but also some important differences — differences the researchers say highlight the need to conduct genetic studies in diverse groups of people.

“People of diverse ancestries have some distinct features in their DNA, and we can find this genetic variation if we include diverse participants in research,” said Manichaikul, of UVA’s Center for Public Health Genomics and Department of Public Health Sciences. “The results from this study bring us a step closer to considering a full spectrum of genetic variation to predict which individuals are at increased risk of fatty acid deficiencies.”

To better understand these genetic differences, Manichaikul and colleagues looked at data collected from more than 1,400 Hispanic-Americans and more than 2,200 African-Americans. This data was obtained through the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium, an international group created to facilitate large-scale genetic analyses. 

Manichaikul and colleagues report that prior genetic findings on fatty-acid metabolism in people of European ancestry often held true for Hispanic- and African-descended people. For example, one location on a particular chromosome had been identified as an important hub for the regulation of fatty acid use in Europeans, and that hub proved important for people of Hispanic and African descent too. There were several such shared genetic influences across the three groups.

But Manichaikul and her team also found notable differences, with several previously unknown genetic sources of variation in fatty-acid levels among both Hispanic-Americans and African-Americans. 

The differences the researchers detected in Hispanic-Americans and African-Americans help explain why their bodies use fatty acids differently. They also suggest answers to questions such as why Hispanic people with significant American Indigenous ancestry often have lower levels of fatty acids in their blood.

The researchers say their new findings, published in Communications Biology, lay the groundwork for future studies to examine how fatty-acid differences may influence the outcomes of diseases such as cancer, or how they affect immune system function. We might then use “precision nutrition” — a carefully tailored diet or strategic supplementation — to improve those outcomes.

“Our study found new fatty acid-related genetic variation that we have never found in our earlier studies that did not include as much genetic diversity,” Manichaikul said. “In our future research, we will continue to include as much ancestral and genetic diversity as possible, so that we can learn how the vast array of variations in human DNA affect people’s health.”  

This article was first published by UVA Health. Read the original.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Josh Barney
Josh Barney

Josh Barney writes about medical discovery at UVA Health and curates UVA's Making of Medicine medical research blog.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Cholesterol regulatory genes predict liver transplant outcomes
Journal News

Cholesterol regulatory genes predict liver transplant outcomes

April 10, 2026

Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Journal News

Lipid signatures for a rare neurological disorder

April 10, 2026

Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Journal News

The dual role of asprosin in chronic fatty liver disease

April 8, 2026

Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Journal News

Novel inhibitor targets RAS-driven cancers

April 7, 2026

Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Journal News

Catching tau in the act

April 2, 2026

Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.